Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/08/202407:56Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
02/08/202407:55GlobeNewswire Inc.Occidental Announces Termination of Exchange Offer and Consent Solicitation for CrownRock NotesNYSE:OXYOccidental Petroleum Corporation
02/08/202407:55Business WireOS Therapies Forms Osteosarcoma Patient Advocacy Advisory BoardAMEX:OSTXOS Therapies Incorporated
02/08/202407:55PR Newswire (US)Sensitech Completes Acquisition of Berlinger & Co. Monitoring Solutions Expanding Life Sciences Cold Chain SolutionsNYSE:CARRCarrier Global Corporation
02/08/202407:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BTSGBrightSpring Health Services Inc
02/08/202407:49PR Newswire (US)AGM Financial Services Bolsters Midwest Presence With Strategic Hires
02/08/202407:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAGPPlains GP Holdings LP
02/08/202407:48PR Newswire (US)Scrum Alliance Launches New Microcredential Course Focused on Strategic Planning and Goal Setting using Agile OKRs
02/08/202407:48Business WireAM Best Affirms Credit Ratings of China Shipowners Mutual Assurance Association
02/08/202407:47Business WireNissan pet-friendly accessories are ready for the whole pack
02/08/202407:46PR Newswire (US)Municipal Credit Union Receives 'Best & Brightest' Company Certification from National Association for Business Resources
02/08/202407:45Alliance NewsAlliance NewsTOP NEWS: Non-farm payrolls miss expectations while jobless rate jumps
02/08/202407:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PAXPatria Investments Ltd
02/08/202407:45Business WireEnfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and FlexibilityNYSE:ENFNEnfusion Inc
02/08/202407:45GlobeNewswire Inc.Key Tronic Corporation Announces Fourth Quarter Reporting DateNASDAQ:KTCCKeyTronic Corporation
02/08/202407:43Alliance NewsAlliance NewsSkinBioTherapeutics lands GBP1.6 million investment to support growthLSE:SBTXSkinbiotherapeutics Plc
02/08/202407:43PR Newswire (US)BIZCLIK MEDIA LAUNCHES THE AUGUST EDITIONS OF SUSTAINABILITY & ENERGY DIGITAL MAGAZINES
02/08/202407:42PR Newswire (US)GLAM Empowers 60 Girls in Partnership With Cisco to Help Bridge the Gender Gap in Tech
02/08/202407:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCBCMacatawa Bank Corporation
02/08/202407:40GlobeNewswire Inc.Key Tronic Corporation Announces Preliminary Results for the Fourth Quarter of Fiscal Year 2024NASDAQ:KTCCKeyTronic Corporation
02/08/202407:39Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BGCPBGC Partners Inc
02/08/202407:39PR Newswire (US)Safe House Project Receives Additional $500,000 from Mecklenburg County through ARPA Funding
02/08/202407:39PR Newswire (US)Former Police Officer Helps Families And Dogs Live Happier Lives Together
02/08/202407:38Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BGCPBGC Partners Inc
02/08/202407:38PR Newswire (Canada)Rappel de Avoine à la banane et aux raisins céréales complètes biologiques pour bébés de marque Baby Gourmet Organic en raison de la bactérie Cronobacter spp
02/08/202407:38PR Newswire (US)Data Governance in the Healthcare Sector Critical to Improve Health Outcomes and Compliance
02/08/202407:36PR Newswire (US)Live Music Entertainment Company MAMMOTH Announces Touring Department
02/08/202407:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:WTFCMWintrust Financial Corporation
02/08/202407:35GlobeNewswire Inc.OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand ViewingTSXV:LNGELNG Energy Group Corp
02/08/202407:35GlobeNewswire Inc.FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and priority review